LUCIUS 卢修斯 达普司他 Daprodustat慢性肾病贫血

达普司他

美国FDA批准上市产品,疗效确切
卢修斯制药(老挝)有限公司出品

Daprodustat

老挝国家食药监局批准上市
老挝国家药检所检测认证

Composition:

慢性肾病贫血

Each film-coated tablet contains

LUCiUS

Daprodustat ....

Indication:

PHARMACEUTICALS

LuciDap is a hypoxia-inducible factor prolvl
hydroxylase (HiF Pi)inhibitor indicated fo
the trealment of anemia due to chronic
kidney disease in adults who have heen
receiving dialvsis for nt lonet fonr m

LuciDap

Dosagp andfiemonth

'Administer orally once daily, with or without

100d.

The recommended dosage
2 mg or 4 mg once. Afterwarde fhe

Daprodustat

FDA批准

can he adinetad aeeot
oc acjusted according to the patient
ards, the dosag
g is the maximum recommended once

Tablets

daily dose.
Storage: in ad
Storage: in a dry place and store at 20°C to
Warniag:
Keen meticine

s out of reach of Children. Do

1mg

hot administer LuciDap during Pregnancy
and Lactation

PLEASE SEE PACKAGE INSERT
Manufactured and Marketed by:

权威认证

LUCIUS
Thongmang village, Xaythany distric
Vientiane Capital, Laos

Www.lucius.lu

Warning : To he sold by retail on prescription
eeru pryscians only, and as directed

Rx Only

100 Tablets

口碑质量

适应症:
适用于治疗接受透析至少四个月的成人慢性肾脏
疾病引起的贫血。
推荐剂量:
1、每日口服一次,随餐或空腹均可。
2、起始剂量基于血红蛋白水平、肝功能和同服药物
来确定;维持剂量及剂量调整,请阅读说明书。